Sci-Tech News Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.

Press releases published on October 9, 2026

Oct. 9, 2026

Cloudastructure to Present at the Webull Emerging & Innovative Companies Webinar on October 14th

Indeterminate GlobeNewswire

Oct. 9, 2026

AZIO AI Signs First Hosting Agreement at Atlas One with Power Champion; 10 MW Contracted, with Expansion Rights to 50 MW Representing Up to Approximately $450 Million in Capacity Reservation Charges

Indeterminate GlobeNewswire

Oct. 9, 2026

Braiin Ltd. to Participate in AI Panel at 2026 Maxim Growth Summit

Indeterminate GlobeNewswire

Oct. 9, 2026

Outlook Therapeutics Names Greg DiPasquale Chief Commercial Officer

Indeterminate GlobeNewswire

Oct. 9, 2026

New Study Shows Cortical Disarray Measurement (CDM®) Can Reflect Microscopic Patterns of Pathology in Frontotemporal Dementia

Indeterminate GlobeNewswire

Oct. 9, 2026

Arcutis Presents ZORYVE® (roflumilast) Data and Real-World Topical Corticosteroid Research at EADV and Fall Clinical

Indeterminate GlobeNewswire

Oct. 9, 2026

Nuvectis Pharma to Participate in the Maxim Growth Summit 2026

Indeterminate GlobeNewswire

Oct. 9, 2026

GoldHaven Intersects Skarn 80 Metres from Prior Deep Skarn Intercept at Kuhn, Strengthening Evidence for Continuity

Indeterminate GlobeNewswire

Oct. 9, 2026

Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial

Indeterminate GlobeNewswire

Oct. 9, 2026

Filana Therapeutics to Participate in the 2026 Maxim Growth Summit

Indeterminate GlobeNewswire

Oct. 9, 2026

Eupraxia Pharmaceuticals to Present at Upcoming American College of Gastroenterology (ACG) and United European Gastroenterology (UEG) Medical Conferences

Indeterminate GlobeNewswire

Oct. 9, 2026

Rezolve Ai Opens Retail to Any AI Shopping Agent with RezolvePay, Targeting a Multi-Trillion-Dollar Commerce Opportunity

Indeterminate GlobeNewswire

Oct. 9, 2026

Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease

Indeterminate GlobeNewswire

Oct. 9, 2026

CENTEL Announces Masternode Participation Model and Blockchain Development Roadmap

Indeterminate GlobeNewswire

Oct. 9, 2026

Stride to Appoint Steven Guttentag and Dylan Haggart to Board of Directors and Form Capital Allocation Committee

Indeterminate GlobeNewswire

Oct. 9, 2026

Trillium Dental’s Dr. Mark Northcott Reveals Which Halloween Treats Damage Kids’ Teeth and Which Are Surprisingly Safe

Indeterminate GlobeNewswire

Oct. 9, 2026

Aura Announces Preliminary Record High Production in Q3 2026 and 9M 2026 Production Results

Indeterminate GlobeNewswire

Oct. 9, 2026

Chemtrade Logistics Income Fund Announces Plans for Conversion to A Simplified New Corporate Structure to Support Long Term Growth

Indeterminate GlobeNewswire

Oct. 9, 2026

Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference 

Indeterminate GlobeNewswire

Oct. 9, 2026

Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia

Indeterminate GlobeNewswire